HEADER GENE REGULATION 07-MAY-21 7MRD TITLE CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN (BD1) OF HUMAN BRDT BOUND TITLE 2 TO GXH-II-082 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN TESTIS-SPECIFIC PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CANCER/TESTIS ANTIGEN 9,CT9,RING3-LIKE PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRDT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PLIC-HIS KEYWDS BRDT, BRD, BET, GENE REGULATION, CONTRACEPTIVE, CANCER EXPDTA X-RAY DIFFRACTION AUTHOR A.CHAN,E.SCHONBRUNN REVDAT 4 18-OCT-23 7MRD 1 REMARK REVDAT 3 24-AUG-22 7MRD 1 JRNL REVDAT 2 03-AUG-22 7MRD 1 JRNL REVDAT 1 18-MAY-22 7MRD 0 JRNL AUTH X.GUAN,N.CHERYALA,R.M.KARIM,A.CHAN,N.BERNDT,J.QI,G.I.GEORG, JRNL AUTH 2 E.SCHONBRUNN JRNL TITL BIVALENT BET BROMODOMAIN INHIBITORS CONFER INCREASED POTENCY JRNL TITL 2 AND SELECTIVITY FOR BRDT VIA PROTEIN CONFORMATIONAL JRNL TITL 3 PLASTICITY. JRNL REF J.MED.CHEM. V. 65 10441 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35867655 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00453 REMARK 2 REMARK 2 RESOLUTION. 1.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1-2575_2829 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.30 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 50693 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.221 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.360 REMARK 3 FREE R VALUE TEST SET COUNT : 1197 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 56.3000 - 2.8910 0.99 5784 140 0.1831 0.1975 REMARK 3 2 2.8910 - 2.2946 1.00 5603 136 0.1998 0.2135 REMARK 3 3 2.2946 - 2.0046 0.99 5505 133 0.1824 0.2044 REMARK 3 4 2.0046 - 1.8213 1.00 5487 132 0.1951 0.2417 REMARK 3 5 1.8213 - 1.6907 0.99 5483 133 0.2137 0.2535 REMARK 3 6 1.6907 - 1.5910 0.99 5382 130 0.2405 0.2450 REMARK 3 7 1.5910 - 1.5114 0.99 5436 131 0.2662 0.2887 REMARK 3 8 1.5114 - 1.4456 0.99 5408 131 0.3047 0.3229 REMARK 3 9 1.4456 - 1.3900 0.99 5408 131 0.3466 0.3577 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.800 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.23 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 1999 REMARK 3 ANGLE : 0.991 2708 REMARK 3 CHIRALITY : 0.072 276 REMARK 3 PLANARITY : 0.007 334 REMARK 3 DIHEDRAL : 13.515 765 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7MRD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-MAY-21. REMARK 100 THE DEPOSITION ID IS D_1000256620. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50695 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.390 REMARK 200 RESOLUTION RANGE LOW (A) : 56.300 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 200 DATA REDUNDANCY : 12.97 REMARK 200 R MERGE (I) : 0.12200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.39 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.43 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 13.65 REMARK 200 R MERGE FOR SHELL (I) : 2.70900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4KCX REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.13 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M HEPES PH 7.5, 25% W/V REMARK 280 POLYETHYLENE GLYCOL 3,350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 17.42500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.30000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.58500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.30000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 17.42500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 31.58500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 137 REMARK 465 GLU B 137 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 204 O HOH A 270 2.05 REMARK 500 NZ LYS A 60 O HOH A 201 2.14 REMARK 500 O HOH B 306 O HOH B 326 2.16 REMARK 500 O HOH A 316 O HOH A 347 2.17 REMARK 500 OD2 ASP B 113 O HOH B 301 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 388 O HOH B 413 1655 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 26 -98.60 -124.34 REMARK 500 VAL A 38 -60.65 -108.45 REMARK 500 LEU A 63 74.51 -118.92 REMARK 500 ALA B 27 85.18 -153.08 REMARK 500 SER B 28 -59.62 -165.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZMV B 201 DBREF 7MRD A 29 137 UNP Q58F21 BRDT_HUMAN 42 150 DBREF 7MRD B 29 137 UNP Q58F21 BRDT_HUMAN 42 150 SEQADV 7MRD GLY A 25 UNP Q58F21 EXPRESSION TAG SEQADV 7MRD ALA A 26 UNP Q58F21 EXPRESSION TAG SEQADV 7MRD ALA A 27 UNP Q58F21 EXPRESSION TAG SEQADV 7MRD SER A 28 UNP Q58F21 EXPRESSION TAG SEQADV 7MRD GLY B 25 UNP Q58F21 EXPRESSION TAG SEQADV 7MRD ALA B 26 UNP Q58F21 EXPRESSION TAG SEQADV 7MRD ALA B 27 UNP Q58F21 EXPRESSION TAG SEQADV 7MRD SER B 28 UNP Q58F21 EXPRESSION TAG SEQRES 1 A 113 GLY ALA ALA SER THR ASN GLN LEU GLN TYR LEU GLN LYS SEQRES 2 A 113 VAL VAL LEU LYS ASP LEU TRP LYS HIS SER PHE SER TRP SEQRES 3 A 113 PRO PHE GLN ARG PRO VAL ASP ALA VAL LYS LEU GLN LEU SEQRES 4 A 113 PRO ASP TYR TYR THR ILE ILE LYS ASN PRO MET ASP LEU SEQRES 5 A 113 ASN THR ILE LYS LYS ARG LEU GLU ASN LYS TYR TYR ALA SEQRES 6 A 113 LYS ALA SER GLU CYS ILE GLU ASP PHE ASN THR MET PHE SEQRES 7 A 113 SER ASN CYS TYR LEU TYR ASN LYS PRO GLY ASP ASP ILE SEQRES 8 A 113 VAL LEU MET ALA GLN ALA LEU GLU LYS LEU PHE MET GLN SEQRES 9 A 113 LYS LEU SER GLN MET PRO GLN GLU GLU SEQRES 1 B 113 GLY ALA ALA SER THR ASN GLN LEU GLN TYR LEU GLN LYS SEQRES 2 B 113 VAL VAL LEU LYS ASP LEU TRP LYS HIS SER PHE SER TRP SEQRES 3 B 113 PRO PHE GLN ARG PRO VAL ASP ALA VAL LYS LEU GLN LEU SEQRES 4 B 113 PRO ASP TYR TYR THR ILE ILE LYS ASN PRO MET ASP LEU SEQRES 5 B 113 ASN THR ILE LYS LYS ARG LEU GLU ASN LYS TYR TYR ALA SEQRES 6 B 113 LYS ALA SER GLU CYS ILE GLU ASP PHE ASN THR MET PHE SEQRES 7 B 113 SER ASN CYS TYR LEU TYR ASN LYS PRO GLY ASP ASP ILE SEQRES 8 B 113 VAL LEU MET ALA GLN ALA LEU GLU LYS LEU PHE MET GLN SEQRES 9 B 113 LYS LEU SER GLN MET PRO GLN GLU GLU HET ZMV B 201 98 HETNAM ZMV N,N'-[(1,16-DIOXO-4,7,10,13-TETRAOXAHEXADECANE-1,16- HETNAM 2 ZMV DIYL)DI(PIPERIDINE-1,4-DIYL)]BIS{4-[(4-{4-CHLORO-3- HETNAM 3 ZMV [(2-METHYLPROPANE-2-SULFONYL)AMINO]ANILINO}-5- HETNAM 4 ZMV METHYLPYRIMIDIN-2-YL)AMINO]-2-FLUOROBENZAMIDE} FORMUL 3 ZMV C66 H84 CL2 F2 N14 O12 S2 FORMUL 4 HOH *264(H2 O) HELIX 1 AA1 SER A 28 VAL A 38 1 11 HELIX 2 AA2 VAL A 38 HIS A 46 1 9 HELIX 3 AA3 SER A 49 GLN A 53 5 5 HELIX 4 AA4 ASP A 65 ILE A 70 1 6 HELIX 5 AA5 ASP A 75 ASN A 85 1 11 HELIX 6 AA6 LYS A 90 ASN A 109 1 20 HELIX 7 AA7 ASP A 113 GLN A 132 1 20 HELIX 8 AA8 THR B 29 VAL B 38 1 10 HELIX 9 AA9 VAL B 38 HIS B 46 1 9 HELIX 10 AB1 SER B 49 GLN B 53 5 5 HELIX 11 AB2 ASP B 65 ILE B 70 1 6 HELIX 12 AB3 ASP B 75 ASN B 85 1 11 HELIX 13 AB4 LYS B 90 ASN B 109 1 20 HELIX 14 AB5 ASP B 113 GLN B 132 1 20 CISPEP 1 GLY B 25 ALA B 26 0 -0.18 CISPEP 2 ALA B 27 SER B 28 0 -6.18 CISPEP 3 PRO B 111 GLY B 112 0 9.52 SITE 1 AC1 29 TRP A 50 PRO A 51 VAL A 56 LYS A 60 SITE 2 AC1 29 LEU A 61 GLN A 62 ASN A 109 ASP A 114 SITE 3 AC1 29 ILE A 115 HOH A 211 HOH A 279 HOH A 296 SITE 4 AC1 29 TRP B 50 PRO B 51 VAL B 56 VAL B 59 SITE 5 AC1 29 LYS B 60 LEU B 61 GLN B 62 LEU B 63 SITE 6 AC1 29 ASN B 109 ILE B 115 LYS B 124 HOH B 325 SITE 7 AC1 29 HOH B 344 HOH B 357 HOH B 367 HOH B 372 SITE 8 AC1 29 HOH B 381 CRYST1 34.850 63.170 112.600 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028694 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015830 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008881 0.00000